|
ARMCX5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.304000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.309900E-02 |
| Normal-vs-Stage2 |
3.946400E-02 |
| Normal-vs-Stage3 |
7.212800E-04 |
| Normal-vs-Stage4 |
1.836440E-04 |
| Stage1-vs-Stage2 |
9.031200E-01 |
| Stage1-vs-Stage3 |
1.286430E-01 |
| Stage1-vs-Stage4 |
4.875800E-02 |
| Stage2-vs-Stage3 |
3.652400E-01 |
| Stage2-vs-Stage4 |
2.031200E-01 |
| Stage3-vs-Stage4 |
6.293800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.364000E-04 |
| Normal-vs-AfricanAmerican |
8.594600E-01 |
| Normal-vs-Asian |
1.881800E-02 |
| Caucasian-vs-AfricanAmerican |
2.182300E-02 |
| Caucasian-vs-Asian |
3.421000E-01 |
| AfricanAmerican-vs-Asian |
1.710560E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.075400E-03 |
| Normal-vs-Female |
2.763400E-03 |
| Male-vs-Female |
8.122400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.161800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.504500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.003220E-03 |
| Normal-vs-Age(81-100Yrs) |
8.480300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.261600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.801600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.687400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.238600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.939200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.379400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.496000E-03 |
| Classical-VS-Follicular |
4.965400E-01 |
| Classical-VS-Other |
4.905800E-01 |
| Classical-VS-Normal |
6.755700E-03 |
| Tall-VS-Follicular |
5.277800E-03 |
| Tall-VS-Other |
5.448000E-01 |
| Tall-VS-Normal |
5.7733999999976E-05 |
| Follicular-VS-Other |
4.567400E-01 |
| Follicular-VS-Normal |
1.090620E-01 |
| Other-VS-Normal |
7.656400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.819800E-03 |
| Normal-vs-N1 |
6.41109999999223E-05 |
| N0-vs-N1 |
5.294100E-02 |
|
|
